0001546927-16-000462.txt : 20160314 0001546927-16-000462.hdr.sgml : 20160314 20160314153355 ACCESSION NUMBER: 0001546927-16-000462 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160311 FILED AS OF DATE: 20160314 DATE AS OF CHANGE: 20160314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Imprimis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-704-4042 MAIL ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Opaleye Management Inc. CENTRAL INDEX KEY: 0001595855 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 161503666 BUSINESS ADDRESS: STREET 1: 175 FEDERAL STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-904-9195 MAIL ADDRESS: STREET 1: 175 FEDERAL STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4/A 1 opaleyeimmyform4filed.xml OWNERSHIP DOCUMENT X0306 4/A 2016-03-11 2016-03-14 1 0001360214 Imprimis Pharmaceuticals, Inc. IMMY 0001595855 Opaleye Management Inc. 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110 0 0 1 0 Common Stock 2016-03-11 2016-03-11 4 P 0 45000 3.60 A 1250000 I See Foonote Securities reported herein for Opaleye Management, Inc. (the "Company) represent Common Stock beneficially owned and held of record by the Company and Opaleye, L.P., a private fund for which the Company serves as the investment manager (the "Fund"). James Silverman is the President and sole shareholder of the Company. The Company, the Fund and Mr. Silverman (the "Reporting Persons") are each beneficial owners and have an address of 175 Federal Street, 6th Floor, Boston, MA 02110. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares and warrants in which the Reporting Persons have no actual pecuniary interest therein. James Silverman, individually 2016-03-14 James Silverman, as Manager of Opaleye GP LLC 2016-03-14 James Silverman, as President of Opaleye Management, Inc. 2016-03-14